MRF evidence report
Evidence date: 2026-10-01. Research observations only.
What can I do with this stock?
Evaluated 2026-10-02T01:37:53.224812+00:00. Closed-session evidence: 2026-10-01. This is a timestamped assessment, not a live trading feed.
Strategy evidence, instrument feasibility and portfolio suitability are separate. Portfolio suitability has not been assessed.
Today: intraday
Evidence unavailable
No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.
- No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.
Next week: five trading sessions
No qualifying opportunity
No candidate with a primary five-session horizon in the coherent source run.
- No candidate with a primary five-session horizon in the coherent source run.
Long term: one to three years
Research only
A financial screen alone does not establish an investment recommendation.
- A current, source-backed thesis and valuation review is required.
Investment evidence
- Statement coverage
- FULL_STATEMENTS
- Financial source retrieved
- 2026-09-23T14:00:19.280049+00:00
Metrics
- latest_annual_period
- 2026-03-31
- revenue
- 311490100000.0
- net_income
- 24261000000.0
- operating_cash_flow
- 44256200000.0
- free_cash_flow
- 29913700000.0
- total_assets
- 319535100000.0
- total_liabilities
- 109787600000.0
- total_equity
- 209745600000.0
- cash
- 3045900000.0
- total_debt
- 32066600000.0
- revenue_growth
- 0.10571033231290006
- earnings_growth
- 0.29787939741504754
- net_margin
- 0.0778869055549438
- roe
- 0.1156686957914731
- debt_to_equity
- 0.1528833024387639
- cash_conversion
- 1.8241704793701825
- free_cash_flow_margin
- 0.09603419177688151
- trailing_pe
- 23.5275
- forward_pe
- 14.6413
- peg_ratio
- Not supplied
- price_to_book
- 2.7136
- dividend_yield
- 0.0017
Other positional research
No qualifying opportunity
No candidate at another positional horizon in the coherent source run.
- No candidate at another positional horizon in the coherent source run.
Decision provenance and limitations
- Decision ID
- decision-2d5a922dde3800a04481af4478718d5fbc02e40bc9e2c233e8ed91a45d174038
- Policy
- stock-decisions-v1
- Evidence bundle hash
- d8a798237e69adceb210e9b610969d931a0a149b3bfdbcb843361cc103e1529c
- market-brief: a7de4d64fedac164d48cdfb9b4081a4666d7f797f7d9c58da304b329b3a61d3c
- validation-registry: b1069587129bfc64a703cdf8322d0294692585b7d67f5472593e4164bbb0c3bc
- financial-statements: b4d40c9e56437bc30fd0238a57ee3e2997dc90766a4175361c09fe514235ff88
- daily-price: fe0bf1c35b7f7ee6c2835d118ad8a74112b45a16bc5d7439ce32d6eab62c44a5
- Conditional research decisions are not orders or personalized position sizes.
- Scenario payoffs are assumptions, not probabilities or expected returns.
- A stop price does not guarantee a maximum loss through a gap or illiquidity.
Download the decision evidence as JSON
Numerical report available. Evidence briefing is queued or awaiting retry.
Cached observations and evidence limits
- Price source verification: REPAIRED.
- The cached closing price on 2026-10-01 was INR 123715.00.
- The trailing 5-session price return was -0.22%.
- The trailing 20-session price return was -6.19%.
- The trailing 60-session price return was -6.94%.
- The trailing 250-session price return was -16.57%.
- Average cached traded value over twenty sessions was INR 429,897,780.
- The closing price was -23.64% below its highest close in the available trailing year.
- Fundamental coverage is FULL_STATEMENTS; retrieved 2026-09-23T14:00:19.280049+00:00 from EODHD.
- The cached financial metric latest annual period is 2026-03-31.
- The cached financial metric revenue growth is 0.10571033231290006.
- The cached financial metric net margin is 0.0778869055549438.
- The cached financial metric roe is 0.1156686957914731.
- The cached financial metric debt to equity is 0.1528833024387639.
- The cached financial metric cash conversion is 1.8241704793701825.
- The cached financial metric free cash flow margin is 0.09603419177688151.
- Historical observations do not establish future returns. No verified current news or catalyst evidence is supplied.